Epinutra
Wageningen
About Epinutra
Epinutra develops natural nutraceuticals based on a strong scientific foundation. We now launch benesco(TM) a dissolve in the mouth natural nutraceutical to support heartburn sufferers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $507.4K
- Funding stage: Seed
- Last round: Seed (Aug 2020)
- Website: epinutra.com
- Phone: 0031 627245842
Industries & Categories
Food and Beverage, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/epinutra-189765 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.